Fondaparinux Sodium

Product NDC: 0781-3465
11-digit product format: 007813465
Labeler code: 0781
Product ID: 0781-3465_3d5a4b69-462b-7e51-e063-6294a90a0721
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Fondaparinux Sodium
Dosage form: INJECTION
Route: SUBCUTANEOUS
Labeler: Sandoz Inc.
Application: ANDA206812
Marketing category: ANDA
Marketing start: 2019-06-18
Substance: FONDAPARINUX SODIUM
Active strength: 7.5 mg/.6mL
Pharmacologic classes: Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A206812-001	FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	2.5MG/0.5ML (2.5MG/0.5ML)	SOLUTION / SUBCUTANEOUS	2018-05-15
A206812-002	FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	5MG/0.4ML (5MG/0.4ML)	SOLUTION / SUBCUTANEOUS	2018-05-15
A206812-003	FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	7.5MG/0.6ML (7.5MG/0.6ML)	SOLUTION / SUBCUTANEOUS	2018-05-15
A206812-004	FONDAPARINUX SODIUM	FONDAPARINUX SODIUM	10MG/0.8ML (10MG/0.8ML)	SOLUTION / SUBCUTANEOUS	2018-05-15

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 168 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A206812-001	FONDAPARINUX SODIUM	2.5MG/0.5ML (2.5MG/0.5ML)	SOLUTION / SUBCUTANEOUS		2018-05-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206812-002	FONDAPARINUX SODIUM	5MG/0.4ML (5MG/0.4ML)	SOLUTION / SUBCUTANEOUS		2018-05-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206812-003	FONDAPARINUX SODIUM	7.5MG/0.6ML (7.5MG/0.6ML)	SOLUTION / SUBCUTANEOUS		2018-05-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206812-004	FONDAPARINUX SODIUM	10MG/0.8ML (10MG/0.8ML)	SOLUTION / SUBCUTANEOUS		2018-05-15	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206812-001	FONDAPARINUX SODIUM	2.5MG/0.5ML	SOLUTION / SUBCUTANEOUS	AP	2018-05-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206812-002	FONDAPARINUX SODIUM	5MG/0.4ML	SOLUTION / SUBCUTANEOUS	AP	2018-05-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206812-003	FONDAPARINUX SODIUM	7.5MG/0.6ML	SOLUTION / SUBCUTANEOUS	AP	2018-05-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206812-004	FONDAPARINUX SODIUM	10MG/0.8ML	SOLUTION / SUBCUTANEOUS	AP	2018-05-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206812-001	FONDAPARINUX SODIUM	2.5MG/0.5ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206812-002	FONDAPARINUX SODIUM	5MG/0.4ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206812-003	FONDAPARINUX SODIUM	7.5MG/0.6ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206812-004	FONDAPARINUX SODIUM	10MG/0.8ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206812-001	FONDAPARINUX SODIUM	2.5MG/0.5ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206812-002	FONDAPARINUX SODIUM	5MG/0.4ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206812-003	FONDAPARINUX SODIUM	7.5MG/0.6ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206812-004	FONDAPARINUX SODIUM	10MG/0.8ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206812-001	FONDAPARINUX SODIUM	2.5MG/0.5ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206812-002	FONDAPARINUX SODIUM	5MG/0.4ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206812-003	FONDAPARINUX SODIUM	7.5MG/0.6ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206812-004	FONDAPARINUX SODIUM	10MG/0.8ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206812-001	FONDAPARINUX SODIUM	2.5MG/0.5ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206812-002	FONDAPARINUX SODIUM	5MG/0.4ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206812-003	FONDAPARINUX SODIUM	7.5MG/0.6ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206812-004	FONDAPARINUX SODIUM	10MG/0.8ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206812-001	FONDAPARINUX SODIUM	2.5MG/0.5ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206812-002	FONDAPARINUX SODIUM	5MG/0.4ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206812-003	FONDAPARINUX SODIUM	7.5MG/0.6ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206812-004	FONDAPARINUX SODIUM	10MG/0.8ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206812-001	FONDAPARINUX SODIUM	2.5MG/0.5ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206812-002	FONDAPARINUX SODIUM	5MG/0.4ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206812-003	FONDAPARINUX SODIUM	7.5MG/0.6ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206812-004	FONDAPARINUX SODIUM	10MG/0.8ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206812-001	FONDAPARINUX SODIUM	2.5MG/0.5ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206812-002	FONDAPARINUX SODIUM	5MG/0.4ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206812-003	FONDAPARINUX SODIUM	7.5MG/0.6ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206812-004	FONDAPARINUX SODIUM	10MG/0.8ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206812-001	FONDAPARINUX SODIUM	2.5MG/0.5ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206812-002	FONDAPARINUX SODIUM	5MG/0.4ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206812-003	FONDAPARINUX SODIUM	7.5MG/0.6ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206812-004	FONDAPARINUX SODIUM	10MG/0.8ML	INJECTABLE / SUBCUTANEOUS	AP	2018-05-15	`d8e5a09893c0…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 160 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A206812-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206812-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206812-003	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206812-004	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206812-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206812-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206812-003	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206812-004	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206812-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206812-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206812-003	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206812-004	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206812-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206812-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206812-003	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206812-004	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206812-001	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206812-002	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206812-003	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206812-004	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206812-001	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206812-002	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206812-003	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206812-004	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206812-001	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206812-002	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206812-003	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206812-004	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206812-001	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206812-002	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206812-003	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206812-004	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206812-001	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206812-002	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206812-003	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206812-004	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206812-001	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206812-002	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206812-003	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206812-004	AP	1	`d06236e962d9…`

Additional Listing Data#

Finished product: Yes
Brand name base: Fondaparinux Sodium
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
FONDAPARINUX SODIUM	7.5 mg/.6mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
X0Q6N9USOZ	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
861356	Internal RxNorm lookup
861360	Internal RxNorm lookup
861363	Internal RxNorm lookup
861365	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
baa50757-a927-4d56-a933-5d7798fe6ab0	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
03ac78a4-5655-4d9a-b2f1-a0919f833364	Product name	5	20250818

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
0781-3465-12	2021-08-03	These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 2001
0781-3465-95	2021-08-03	These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 2001
0781-3465-12	2021-07-23	These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 2001
0781-3465-95	2021-07-23	These highlights do not include all the information needed to use FONDAPARINUX SODIUM INJECTION safely and effectively. See full prescribing information for FONDAPARINUX SODIUM INJECTION. FONDAPARINUX SODIUM injection, for subcutaneous use Initial U.S. Approval: 2001

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0781-3465-12	Fondaparinux Sodium	2 in 1 CARTON	INJECTION	2	18
0781-3465-94	Fondaparinux Sodium	0.6 mL in 1 SYRINGE	INJECTION	0.6	18
0781-3465-95	Fondaparinux Sodium	10 in 1 CARTON	INJECTION	10	18

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0781-3465	FONDAPARINUX SODIUM INJECTION [SANDOZ INC.]	17	Current NDC, Legacy NDC, 3 package rows	20250302_baa50757-a927-4d56-a933-5d7798fe6ab0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Fondaparinux Sodium	FONDAPARINUX SODIUM	Sandoz Inc.	baa50757-a927-4d56-a933-5d7798fe6ab0	2025-08-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206812 application number: ANDA206812 ndc (product): 0781-3465

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X0Q6N9USOZ	FONDAPARINUX SODIUM	114870-03-0	FONDAPARINUX SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
861356	fondaparinux sodium 10 MG in 0.8 ML Prefilled Syringe	PSN	baa50757-a927-4d56-a933-5d7798fe6ab0	18
861360	fondaparinux sodium 2.5 MG in 0.5 ML Prefilled Syringe	PSN	baa50757-a927-4d56-a933-5d7798fe6ab0	18
861363	fondaparinux sodium 5 MG in 0.4 ML Prefilled Syringe	PSN	baa50757-a927-4d56-a933-5d7798fe6ab0	18
861365	fondaparinux sodium 7.5 MG in 0.6 ML Prefilled Syringe	PSN	baa50757-a927-4d56-a933-5d7798fe6ab0	18
861363	0.4 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe	SCD	baa50757-a927-4d56-a933-5d7798fe6ab0	18
861360	0.5 ML fondaparinux sodium 5 MG/ML Prefilled Syringe	SCD	baa50757-a927-4d56-a933-5d7798fe6ab0	18
861365	0.6 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe	SCD	baa50757-a927-4d56-a933-5d7798fe6ab0	18
861356	0.8 ML fondaparinux sodium 12.5 MG/ML Prefilled Syringe	SCD	baa50757-a927-4d56-a933-5d7798fe6ab0	18
861356	fondaparinux sodium 10 MG per 0.8 ML Prefilled Syringe	SY	baa50757-a927-4d56-a933-5d7798fe6ab0	18
861360	fondaparinux sodium 2.5 MG per 0.5 ML Prefilled Syringe	SY	baa50757-a927-4d56-a933-5d7798fe6ab0	18
861363	fondaparinux sodium 5 MG per 0.4 ML Prefilled Syringe	SY	baa50757-a927-4d56-a933-5d7798fe6ab0	18
861365	fondaparinux sodium 7.5 MG per 0.6 ML Prefilled Syringe	SY	baa50757-a927-4d56-a933-5d7798fe6ab0	18

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0781-3465-12	00781346512	2 SYRINGE in 1 CARTON (0781-3465-12) / .6 mL in 1 SYRINGE (0781-3465-94)	2 syringe	2019-06-18	0000-00-00	No	No	Current
0781-3465-94	00781346594	0.6 mL in 1 SYRINGE	0.6 ml					Historical
0781-3465-95	00781346595	10 SYRINGE in 1 CARTON (0781-3465-95) / .6 mL in 1 SYRINGE (0781-3465-94)	10 syringe	2019-06-18	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Fondaparinux Sodium	Sandoz Inc. \| Jiangsu Hengrui Pharmaceuticals Co., Ltd. \| Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Dongjin Road Site)	2025-08-27	HUMAN PRESCRIPTION DRUG LABEL	18